Kuehl, P. J., Grimes, M. J., Dubose, D., Burke, M., Revelli, D. A., Gigliotti, A. P., . . . Tessema, M. (2018). Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model. Drug Deliv.
Chicago Style citaatKuehl, Philip J., Marcie J. Grimes, Devon Dubose, Michael Burke, David A. Revelli, Andrew P. Gigliotti, Steven A. Belinsky, en Mathewos Tessema. "Inhalation Delivery of Topotecan Is Superior to Intravenous Exposure for Suppressing Lung Cancer in a Preclinical Model." Drug Deliv 2018.
MLA citatieKuehl, Philip J., et al. "Inhalation Delivery of Topotecan Is Superior to Intravenous Exposure for Suppressing Lung Cancer in a Preclinical Model." Drug Deliv 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.